Schaefer, Joseph, R. Fidaxomicin PresentationJoseph Schaefer
?
Venugopal and Johnson found that fidaxomicin was effective in treating C. difficile infections while minimizing damage to gut flora. The minimal inhibitory concentration needed to eliminate 90% of C. difficile isolates was lower than for vancomycin and metronidazole. However, sensitivity to these antibiotics decreased over time, suggesting mechanisms of resistance. Artsimovitch, Seddon, and Sears proposed that fidaxomicin inhibits bacterial transcription by binding to and altering the RNA polymerase β' subunit, preventing DNA loading and transcription initiation. Bartsch, Umscheid, Fishman, and Lee found that fidaxomicin is currently not cost-effective compared to vancomycin and metronid
全新 Windows Server 2019 容器技術及邁向與 Kubernetes 整合之路 (Windows Server 高峰會)Will Huang
?
Windows Server 2019 隨之而來的容器功能,帶領 Windows 容器化邁向另一個里程碑。本次演講將介紹全新容器功能,以及跟 Kubernetes 整合的歷程,並透過線上展示 Windows Server 2019 加入到 Kubernetes 叢集的完整步驟!
? Windows Server 高峰會
https://www.microsoft.com/taiwan/events/windows-server-2019/
全新 Windows Server 2019 容器技術及邁向與 Kubernetes 整合之路 (Windows Server 高峰會)Will Huang
?
Windows Server 2019 隨之而來的容器功能,帶領 Windows 容器化邁向另一個里程碑。本次演講將介紹全新容器功能,以及跟 Kubernetes 整合的歷程,並透過線上展示 Windows Server 2019 加入到 Kubernetes 叢集的完整步驟!
? Windows Server 高峰會
https://www.microsoft.com/taiwan/events/windows-server-2019/